219 filings
Page 3 of 11
8-K
lupb65djnxv51o
7 Nov 22
In the Court of Chancery of the State of Delaware
5:05pm
S-8
v2l2wd
5 Oct 22
Registration of securities for employees
5:20pm
8-K
andmdty8
8 Aug 22
REATA PHARMACEUTICALS, INC. ANNOUNCES Second QUARTER 2022 FINANCIAL
6:45am
8-K
5hjp vlig513kpt
12 Jul 22
Reata Announces the Appointment of Steven W. Ryder, M.D. to its Board of Directors
4:05pm
8-K
fmrbr1 l9g04
9 Jun 22
Departure of Directors or Certain Officers
4:07pm
8-K
f0lww74g2t0jy 8s6pnc
10 May 22
Reata Pharmaceuticals, Inc. Announces First Quarter 2022 Financial Results and Provides an Update on Clinical Development Programs
6:48am
DEFA14A
rjku44ay9jw41uel
29 Apr 22
Additional proxy soliciting materials
7:01am
S-8
hho91s5z6ykqr
18 Mar 22
Registration of securities for employees
4:02pm
8-K
oolgogbv b1
2 Mar 22
Departure of Directors or Certain Officers
4:00pm
8-K
oxlwklqsl09ipvv
28 Feb 22
Reata Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2021 Financial Results and Provides an Update on Clinical Development Programs
6:46am
8-K
b9rzunfbywr8n46i4z
7 Feb 22
Departure of Directors or Certain Officers
4:05pm
S-3ASR
nbjte
8 Nov 21
Automatic shelf registration
7:11am
8-K
yklr7ld9h
8 Nov 21
Reata Pharmaceuticals, Inc. Announces Third Quarter 2021 Financial Results and Provides an Update on Clinical Development Programs
6:45am
8-K
hq55tm4z255jx3d
22 Oct 21
Departure of Directors or Certain Officers
6:02am
8-K
fz0wai70r lu
20 Aug 21
Entry into a Material Definitive Agreement
4:19pm